AeroLeads people directory · profile

Christopher Treleaven Email & Phone Number

Business Operations Specialist at Voyager Therapeutics, Inc.
Location: Greater Boston, United States 8 work roles 2 schools
1 work email found @bluebirdbio.com LinkedIn matched
✓ Verified July 2026 4 data sources Profile completeness 86%

Contact Signals · 1 work email

Work email c****@bluebirdbio.com
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Business Operations Specialist
Location
Greater Boston, United States
Company size

Who is Christopher Treleaven? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Christopher Treleaven is listed as Business Operations Specialist at Voyager Therapeutics, Inc., a with 177 employees, based in Greater Boston, United States. AeroLeads shows a work email signal at bluebirdbio.com and a matched LinkedIn profile for Christopher Treleaven.

Christopher Treleaven previously worked as Associate Director, Toxicology at Voyager Therapeutics, Inc. and Associate Director at Avrobio Inc.. Christopher Treleaven holds Bachelor’S Degree, Business Managment, A from University Of Phoenix.

Company email context

Email format at Voyager Therapeutics, Inc.

This section adds company-level context without repeating Christopher Treleaven's masked contact details.

{first_initial}{last}@bluebirdbio.com
86% confidence

AeroLeads found 1 current-domain work email signal for Christopher Treleaven. Compare company email patterns before reaching out.

Profile bio

About Christopher Treleaven

I am an Associate Director of Toxicology with diverse scientific operations and program management experience within drug discovery. Broad pharmacology experience in small molecule and gene therapy approaches within neurodegenerative, lysosomal storage, and additional genetic disorders. An accomplished nonclinical scientist with expertise in managing and collaborating with internal (discovery, CMC, clinical, regulatory) and external stakeholders to drive nonclinical safety strategy in the advancement of the therapeutic pipeline. Proficient in creating an infrastructure of CRO’s supporting pipeline needs and timing with an emphasis on compatibility, technical expertise, quality (GLP, Compliance), and responsiveness. Comfortable authoring and/or reviewing reports for internal decision making, and in preparation for submission.

Current workplace

Christopher Treleaven's current company

Company context helps verify the profile and gives searchers a useful next step.

Voyager Therapeutics, Inc.
Voyager Therapeutics, Inc.
Business Operations Specialist
Boston, MA, US
Employees
177
AeroLeads page
8 roles · 29 years

Christopher Treleaven work experience

A career timeline built from the work history available for this profile.

Associate Director, Toxicology

Current

Lexington, Massachusetts, United States

• Serve as a subject matter expert and nonclinical toxicology representative on project teams.• In conjunction with program teams and senior leadership, develop toxicology strategies and provide expert support in subject area.• Work in close alignment with project leaders to provide safety strategies for novel therapeutics in our pipeline, coordinate research activities supporting project progression and decision making, and assist with the management of toxicology data for use in presentations.• Experienced in Good Lab Practices (GLP) environment to act as study monitor for GLP toxicology studies conducted at external contract research organization (CRO) sites.• Directly interface with CROs to request quotes and derive cost estimates and work closely with our Finance team to develop program budgets. Additional responsibilities include working closely with the Contracts team to develop confidentiality agreements, statements of work and track all expenses and invoices.• Responsible for all sub-vendor activities that use specialized assays and endpoints to support GLP toxicology studies.• Finalize toxicology reports and all sub-vendor reports, manage the tabular presentation of data in accordance with CTD format and have a familiarity with SEND requirements.• Maintain a general understanding of biologics and gene therapy literature, as well as the scientific literature related to the specific drug discovery projects.

Jan 2024 - Present

Associate Director

Avrobio Inc.

Cambridge, Massachusetts, United States

Jan 2021 - Jul 2023

Senior Manager

Cambridge, Massachusetts, United States

o o Provided timely and resource-efficient execution of all preclinical safety activities advancing ex vivo gene therapies into Phase I/II testing.o Ensured all Preclinical aspects of IND/CTA planning are fully supported, including budgeting, contracting, program team strategy, execution of in-life studies, bioanalytical testing, and preclinical components of regulatory submissions.o Directed execution of outsourced studies including evaluated and identified appropriate CRO sites, budget and contracting, protocol creation, direct oversight of execution, and timely and accurate report generation. o Developed in vivo infrastructure; protocols, SOPs, operational processes, reporting timelines and execution, budget forecasting and management with keeping regulatory oversight in mind (FDA, AAALAC).o Directed Avrobio’s first internally run GLP-like IND enabling study resulting in robust scientific data backing the safety of our treatment for advancement of the Pompe program.o Served as an in vivo scientific technical leader for internal studies assuring accurate resource-efficient, impactful results.o Pioneered an internal in vivo review meeting with technical staff, scientists, and preclinical development ensuring cohesion in decision making.o Coordinated test article availability, animal availability, daily technical schedules (including scheduling technical support from CRO’s), and vivarium capacity to produce resource-efficient execution of studies.o Collaborated with a team in developing an integrated study management system, tying in Preclinical, Legal, and Finance teams resulting in timely and resource-efficient study management.

Mar 2020 - Jan 2021

Senior Manager

Cambridge, Ma

o o Directed oversight of all activities involved with running a 7000 sq ft vivarium. Controlled staffing, training, record keeping, managing of day-to-day operations and in vivo study execution.o Established in-house operations and technical staff to manage expedited growtho Designed and oversaw 1200 sq. ft. of additional lab spaceo Collaborated with scientists, preclinical team, and vivarium staff driving execution of all immune-oncology and gene editing studies.o Provided oversight for the IACUC on policy, procedures and protocol implementation.o Collaborated with facilities team ensuring vivarium physical needs were met and constant improvements being made.o Managed 12 employees across multiple disciplines: ensuring compliance, professional growth, and providing BBB support structure.o Pioneered a companywide online training program as requested by federal and local agencies.o Authored in-house policies on the use of vertebrate animals for research and the management of IACUC protocols.

Jul 2018 - Mar 2020

Manager, Comparative Medicine

Cambridge, Ma

o Managed vivarium administration and operationso Controlled staffing, training, SOP generation, in-house policies and protocol creation, record keeping, day-to-day operations, routine animal care.o Managed the needs of on-going studies ensuring coverage and accountability for all aspects within the facility.o Collaborated with biological and chemistry scientists in the design, execution, and analysis of in vivo PK and drug transporter studies supporting small molecule pharmaceuticals. o Interacted with local (Cambridge Commission) and federal agencies (DEA) resulting in consistent compliance with regulations.o Managed Neurosurgical and Neuro-Behavioral suites providing training and oversight.o Provided oversight for the IACUC on policy, procedures and protocol implementation. Acting IACUC chair.o Pioneered a companywide online training program as requested by federal and local agencies.o Co-authored 1 publication.

Oct 2015 - Jul 2018

Principal Research Associate

o Collaborated with a team in the development and validation of therapeutic strategies to target Amyotrophic Lateral Sclerosis, Angelman Syndrome, and Alzheimer’s Disease using discovery gene therapy.o Designed studies, coordinated, supervised, and assisted research teams in executing experiments and managing and analyzing data.o Organized and presented scientific data at in-house meetings and related conferences.o Expanded surgical and behavioral capabilities by validating an extensive list of behavior tests, new surgical techniques, and CNS tissue harvest methods resulting in a more comprehensive approach treatment administration and data analysis.o Co-authored 18 research publications including 2 first authorships.o Characterized SOD1 mouse model using behavior testing and biochemical analysis in the evaluation of an animal model of ALS.

Sep 1998 - Oct 2015

Laboratory Technologist

Framingham, Ma

o Provided technical support for rodent studies including but not limited to rodent handling, compound administration (IP, IM, IV, ID and SC), oral gavage, retro-orbital bleeding, cardiac puncture, transcardial perfusion, necropsy Provided GLP large animal surgical support for the cardiovascular, orthopedic, and gene therapy portfolios.o Involved in all aspects of in-vivo facility logistics: animal care, technical procedures, clean and dirty washrooms, incoming animals, monitored and maintenance of breeding colonies.

1998 - 2006 ~8 yrs
Team & coworkers

Colleagues at Voyager Therapeutics, Inc.

Other employees you can reach at voyagertherapeutics.com. View company contacts for 177 employees →

2 education records

Christopher Treleaven education

FAQ

Frequently asked questions about Christopher Treleaven

Quick answers generated from the profile data available on this page.

What company does Christopher Treleaven work for?

Christopher Treleaven works for Voyager Therapeutics, Inc..

What is Christopher Treleaven's role at Voyager Therapeutics, Inc.?

Christopher Treleaven is listed as Business Operations Specialist at Voyager Therapeutics, Inc..

What is Christopher Treleaven's email address?

AeroLeads has found 1 work email signal at @bluebirdbio.com for Christopher Treleaven at Voyager Therapeutics, Inc..

Where is Christopher Treleaven based?

Christopher Treleaven is based in Greater Boston, United States while working with Voyager Therapeutics, Inc..

What companies has Christopher Treleaven worked for?

Christopher Treleaven has worked for Voyager Therapeutics, Inc., Avrobio Inc., Avrobio, Bluebird Bio, and Sarepta Therapeutics.

Who are Christopher Treleaven's colleagues at Voyager Therapeutics, Inc.?

Christopher Treleaven's colleagues at Voyager Therapeutics, Inc. include Yohanes Abera, Usman Hameedi, Ms, Andrew J., Joseph Clement, and Rupinderjit Kaur.

How can I contact Christopher Treleaven?

You can use AeroLeads to view verified contact signals for Christopher Treleaven at Voyager Therapeutics, Inc., including work email, phone, and LinkedIn data when available.

What schools did Christopher Treleaven attend?

Christopher Treleaven holds Bachelor’S Degree, Business Managment, A from University Of Phoenix.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.

People with similar names

Check these profiles if this is not the Christopher Treleaven you were looking for.

View similar profiles